SeaCrest Wealth Management’s Immune Design Corp. IMDZ Stock Holding History

SeaCrest Wealth Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-133	Closed	-$1K	–	2206
2019 Q1	$1K	Hold	133	–	–	﹤0.01%	2123
2018 Q4	$0	Hold	133	–	–	﹤0.01%	2432
2018 Q3	$0	Sell	133 -133	-50%	-$499	﹤0.01%	2414
2018 Q2	$1K	Hold	266	–	–	﹤0.01%	2183
2018 Q1	$1K	Buy	+266	New	+$942	﹤0.01%	2176

SeaCrest Wealth Management's IMDZ Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 133 shares — an estimated $1K sold.

SeaCrest Wealth Management first reported a position in IMDZ in Q1 2018 and held it in 5 quarters. The position peaked at $1K in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.

SeaCrest Wealth Management reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 133 Immune Design Corp. shares in Q2 2019, an estimated $1K.
SeaCrest Wealth Management first reported a position in Immune Design Corp. in Q1 2018 and held it in 5 quarters.
SeaCrest Wealth Management's Immune Design Corp. position peaked at $1K in Q1 2019.
0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.